FDA Adverse Event Malfunction Summary report: N

ACCESS

MDR report key: 2862957 · Received December 10, 2012

Report

Report Number
1416980-2012-06672
Event Type
Malfunction
Date Received
December 10, 2012
Date of Event
November 15, 2012
Report Date
November 15, 2012
Manufacturer
BAXTER HEALTHCARE
Product Code
FPA
PMA / PMN Number
K961225
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE CUSTOMER REPORTED CONDITION WAS CONFIRMED DURING SAMPLE EVALUATION. ONE DEFECTIVE SAMPLE WAS RETURNED AT THE PLANT FOR EVALUATION. VISUAL INSPECTION REVEALED SPOTS ON THE TUBING. NO OTHER TEST WAS PERFORMED. THE ASSIGNABLE ROOT CAUSE OF THE REPORTED CONDITION IS UNKNOWN. SHOULD ADDITIONAL INFORMATION BE RECEIVED, A FOLLOW-UP MEDWATCH WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). INITIAL EVALUATION CONFIRMED THE REPORTED CONDITION. UPON COMPLETION OF BAXTER'S INVESTIGATION, A FOLLOW-UP WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). THE SAMPLE IS REPORTED TO BE AVAILABLE FOR EVALUATION. A BATCH REVIEW CANNOT BE PERFORMED SINCE THERE WAS NO LOT NUMBER PROVIDED. IF THE SAMPLE IS RECEIVED OR ADDITIONAL INFORMATION BECOMES AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

THE THEATRE MANAGER OF THE FACILITY REPORTED TO BAXTER (B)(4) OF A CONTINU-FLO SOLUTION ADMINISTRATION SET WITH THREE LUER ACTIVATED VALVES IN WHICH OPERATOR OBSERVED VISIBLE SPOTS ON/IN THE TUBING. THE REPORTED CONDITION OCCURRED DURING PRIMING THE SET WITH AN UNKNOWN SOLUTION. THE SPOTS DID NOT APPEAR TO MOVE WITH THE SOLUTION DURING PRIMING. THERE IS NO REPORT OF PATIENT INVOLVEMENT, INJURY/ADVERSE EVENTS, OR MEDICAL INTERVENTION IN ASSOCIATION WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS SET, ADMINISTRATION, INTRAVASCULAR FPA BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1